Nervgen Pharma Corp (NGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2000 | 12-1999 | 12-1998 | |
| Assets | |||
| Current Assets | |||
| Other current assets | 630 | 2,320 | 0 |
| TOTAL | $630 | $2,320 | $N/A |
| Non-Current Assets | |||
| Other Non-Current Assets | 5,390 | 1,280 | 540 |
| TOTAL | $5,390 | $1,280 | $540 |
| Total Assets | $6,020 | $3,600 | $540 |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 1,220 | 590 | 1,060 |
| Accrued Expenses | 4,590 | 3,720 | 1,430 |
| Other current liabilities | 360 | 3,370 | 3,060 |
| TOTAL | $8,180 | $9,810 | $7,460 |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 0 | 2,830 | 0 |
| TOTAL | $1,560 | $2,830 | $4,170 |
| Total Liabilities | $9,740 | $12,640 | $11,630 |
| Shareholders' Equity | |||
| Common Shares | 20 | 10 | 10 |
| Other shareholders' equity | -1,150 | -2,840 | -3,020 |
| TOTAL | $192,320 | $110,740 | $108,470 |
| Total Liabilities And Equity | $202,060 | $123,380 | $120,100 |